Logo En IconLogo Mark IconIcelandic Intellectual Property Office
Plus Black IconMortgagePlus Black IconLicense

SPC260

Galcanesúmab

  • Status:
    Veitt
  • Application date:
    28.3.2019
  • Application published:
    15.4.2019
  • Grant published:
    15.11.2020
  • Max expiry date:
    15.11.2033
  • Medicine name:
    Emgality
  • Medicine for children:
    No

Timeline

Today
28.3.2019Application
15.4.2019Publication
15.11.2020Registration
15.11.2033Expires

Marketing license

  • IS authorization number:
    EU/1/18/1330/001-002; EU/1/18/1330/003-004
  • Date:
    3.12.2018
  • Foreign authorization number:
    EU/1/18/1330
  • Date:
    14.11.2018

Owner

  • Name:
    Eli Lilly and Company
  • Address:
    Lilly Corporate Center, Indianapolis US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents